The notion that low IGF‐1 action may be protective from some diseases, such as cancer, but predispose to others, is particularly relevant to older humans, where somatopause leads to age‐related declines in GH/IGF‐1 (Ashpole et al., 2014). Here, IGF1 is linked to cancer.